Magnetic Resonance Evaluation of Transplanted Mesenchymal Stem Cells After Myocardial Infarction in Swine

Canadian Journal of Cardiology

Volumn 27, Issue 6, 2011, Pages 818-825

  Yang, Ke ^a   Xiang, Peng ^b   Zhang, Chengxi ^a   Zou, Liyuan ^a   Wu, Xiao ^a   Gao, Ya ^a   Kang, Zhuang ^a   He, Keke ^a   Liu, Jinlai ^a   Peng, Chaoquan ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CELL DIFFERENTIATION; CONTROLLED STUDY; HEART FUNCTION; HEART INFARCTION; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN;

ANIMALS; DISEASE MODELS, ANIMAL; MAGNETIC RESONANCE IMAGING, CINE; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; MYOCARDIUM; POSTOPERATIVE PERIOD; REPRODUCIBILITY OF RESULTS; SWINE; SWINE, MINIATURE;

EID: 82155162416     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2011.07.633     Document Type: Article

References (30)

1. Wu J.C., Abraham M.R., Kraitchman D.L. Current perspectives on imaging cardiac stem cell therapy. J Nucl Med 2010, 51:128-136.
2. Laflamme M.A., Murry C.E. Regenerating the heart. Nat Biotechnol 2005, 23:845-856.
3. Wollert K.C., Drexler H. Clinical applications of stem cells for the heart. Circ Res 2005, 96:151-163.
4. Song Y.S., Ku J.H., Song E.S., et al. Magnetic resonance evaluation of human mesenchymal stem cells in corpus cavernosa of rats and rabbits. Asian J Androl 2007, 9:361-367.
5. Bulte J.W., Duncan I.D., Frank J.A. In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J Cereb Blood Flow Metab 2002, 22:899-907.
6. Son K.R., Chung S.Y., Kim H.C., et al. MRI of magnetically labeled mesenchymal stem cells in hepatic failure model. World J Gastroenterol 2010, 16:5611-5615.
7. Yoo J.H., Park C., Jung D.I., et al. In vivo cell tracking of canine allogenic mesenchymal stem cells administration via renal arterial catheterization and physiopathological effects on the kidney in two healthy dogs. J Vet Med Sci 2010, 12:269-274.
8. Cheng J.L., Yang Y.J., Li H.L., Wang J., Wang M.H., Zhang Y. In vivo tracing of superparamagnetic iron oxide-labeled bone marrow mesenchymal stem cells transplanted for traumatic brain injury by susceptibility weighted imaging in a rat model. Chin J Traumatol 2010, 13:173-177.
9. Wang H.H., Wang Y.X., Leung K.C., et al. Durable mesenchymal stem cell labelling by using polyhedral superparamagnetic iron oxide nanoparticles. Chemistry 2009, 15:12417-12425.
10. Majumdar M.K., Keane-Moore M., Buyaner D., et al. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 2003, 10:228-241.
11. Le Blanc K., Tammik C., Rosendahl K., Zetterberg E., Ringdén O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003, 31:890-896.
12. Di Nicola M., Carlo-Stella C., Magni M., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3838-3843.
13. He G., Zhang H., Wei H., et al. In vivo imaging of bone marrow mesenchymal stem cells transplanted into myocardium using magnetic resonance imaging: a novel method to trace the transplanted cells. Int J Cardiol 2007, 114:4-10.
14. Frank J.A., Zywicke H., Jordan E.K., et al. Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad Radiol 2002, 9:484-487.
15. Arbab A.S., Bashaw L.A., Miller B.R., et al. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 2003, 229:838-846.
16. Arbab A.S., Yocum G.T., Kalish H., et al. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004, 104:1217-1223.
17. Kostura L., Kraitchman D.L., Mackay A.M., Pittenger M.F., Bulte J.W. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 2004, 17:513-517.
18. Beek A.M., Kühl H.P., Bondarenko O., et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol 2003, 42:895-901.
19. Reddy A.M., Kwak B.K., Shim H.J., et al. In vivo tracking of mesenchymal stem cells labeled with a novel chitosan-coated superparamagnetic iron oxide nanoparticles using 3.0T MRI. J Korean Med Sci 2010, 25:211-219.
20. Jing X.H., Yang L., Duan X.J., et al. In vivo MR imaging tracking of magnetic iron oxide nanoparticle labeled, engineered, autologous bone marrow mesenchymal stem cells following intra-articular injection. Joint Bone Spine 2008, 75:432-438.
21. Daldrup-Link H.E., Rudelius M., Piontek G., et al. Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment. Radiology 2005, 234:197-205.
22. Loebinger M.R., Kyrtatos P.G., Turmaine M., et al. Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Res 2009, 69:8862-8867.
23. Evgenov N.V., Medarova Z., Pratt J., et al. In vivo imaging of immune rejection in transplanted pancreatic islets. Diabetes 2006, 55:2419-2428.
24. Kriz J., Jirák D., Girman P., et al. Magnetic resonance imaging of pancreatic islets in tolerance and rejection. Transplantation 2005, 80:1596-1603.
25. Tang Y.L., Zhao Q., Qin X., et al. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg 2005, 80:229-236.
26. Kajstura J., Rota M., Whang B., et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 2005, 96:127-137.
27. Mangi A.A., Noiseux N., Kong D., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003, 9:1195-1201.
28. Nygren J.M., Jovinge S., Breitbach M., et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004, 10:494-501.
29. He A., Jiang Y., Gui C., Sun Y., Li J., Wang J.A. The antiapoptotic effect of mesenchymal stem cell transplantation on ischemic myocardium is enhanced by anoxic preconditioning. Can J Cardiol 2009, 25:353-358.
30. Fraidenraich D., Stillwell E., Romero E., et al. Rescue of cardiac defects in id knockout embryos by injection of embryonic stem cells. Science 2004, 306:247-252.